TrialArteriosclerosis, thrombosis, and vascular biology2020

PAR1 (Protease-Activated Receptor 1) Pepducin Therapy Targeting Myocardial Necrosis in Coronary Artery Disease and Acute Coronary Syndrome Patients Undergoing Cardiac Catheterization: A Randomized, Placebo-Controlled, Phase 2 Study.

Athan Kuliopulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.